B7 co-stimulation antagonizes RORγt+ regulatory T cells and tolerance to gut microbiota 2254003
The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)
DOI: 10.1093/jimmun/vkag141.204 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Mengze Lyu und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Regulatory T (Treg) cells recognizing dietary or microbiota-derived antigens express RORγt and are essential for intestinal immune tolerance. A recent paradigm-shifting finding revealed that these cells require major histocompatibility complex class II (MHCII) on RORγt+ antigen-presenting cells (APCs) to provide signal one. Here, we evaluated signal two and found that broad blockade of co-stimulatory molecules B7-1 (CD80) and B7-2 (CD86) unexpectedly provoked the expansion of microbiota-specific RORγt+ Treg cells.
Methods
Cutting-edge transgenic, knockout, and adoptive-transfer mouse models were employed to define how the induction of RORγt+ Treg cells is regulated by MHCII (signal one) from RORγt+ APCs and B7 co-stimulation (signal two) from non-RORγt+ APCs to maintain immune tolerance to gut microbiota. Flow cytometry, ex vivo T cell differentiation, histology, and colitis models induced by Helicobacter hepaticus plus anti—IL-10R antibody, combined with co-stimulation blockade and CTLA4-Ig treatment, were integrated to dissect the interplay between RORγt+ APCs and RORγt+ Tregs.
Results
Mechanistically, B7/CD28-dependent Akt signaling antagonizes the core transcriptional program of RORγt+ Treg cells through the Forkhead box protein O1 (Foxo1) pathway. The expansion of RORγt+ Tregs was recapitulated by CTLA4-Ig but required MHCII (signal one) on RORγt+ APCs together with inhibition of B7 co-stimulation (signal two) from non-RORγt+ APCs. CTLA4-Ig treatment during pathobiont colonization and IL-10R blockade restored microbiota-specific RORγt+ Treg generation and protected against experimental colitis, reducing IL-17+ and TNF+ T cells.
Conclusion
These results mechanistically define that B7 co-stimulation limits microbiota-specific RORγt+ Treg cells, while identifying CTLA4-Ig as an approach to enhance immune tolerance and reduce inflammatory cytokines in the intestine when acting in concert with RORγt+ APCs, provoking a novel therapeutic strategy for patients with chronic intestinal inflammation. Funding Source NIH/NCI - K99CA290052 Topic Categories Mucosal and Regional Immunology (MUC)
Zitieren
APA
Lyu, M., & Sonnenberg, G. (2026). B7 co-stimulation antagonizes RORγt+ regulatory T cells and tolerance to gut microbiota 2254003. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.204
Vancouver
Lyu M, Sonnenberg G. B7 co-stimulation antagonizes RORγt+ regulatory T cells and tolerance to gut microbiota 2254003. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.204
BibTeX
@article{Lyu2026,
author = {Lyu, Mengze and Sonnenberg, Gregory},
title = {B7 co-stimulation antagonizes RORγt+ regulatory T cells and tolerance to gut microbiota 2254003},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {Supplement_1},
doi = {10.1093/jimmun/vkag141.204}
}
EUVIMED